Humana Inc.
Humana Reports Q4 2024 Results and Provides 2025 Guidance
Summary
Humana Inc. reported a net loss per share of $5.76 on a GAAP basis and $2.16 on an Adjusted basis for Q4 2024. For the full year 2024, the company reported GAAP EPS of $9.98 and Adjusted EPS of $16.21. Humana affirmed its Adjusted FY 2025 EPS guidance to be at least in line with 2024 results, anticipating GAAP EPS of approximately $15.88 and Adjusted EPS of approximately $16.25. The company expects an individual Medicare Advantage annual membership decline of about 550,000 from 2024 levels.
Profitelligence Alerts
Get alerts for HUM
Be first to know when Humana Inc. files with the SEC.
Filing Categories
Exhibits (3)
Advertisement
About Humana Inc.
Humana Inc. is a leading healthcare insurance company that primarily focuses on offering comprehensive health insurance products and services. It operates in the insurance sector and is a significant player in the Medicare Advantage market, providing coverage solutions for senior citizens eligible for Medicare. Additionally, Humana boasts a diverse range of health plans, including individual, group medical plans, and specialty products like dental and vision care. The company extends its services to various sectors, including government-sponsored healthcare programs and commercial employers, emphasizing wellness and preventive care. Humana’s offerings are designed to meet the needs of both individual consumers and large organizations, ensuring tailored healthcare coverage. Based in Louisville, Kentucky, Humana is a crucial component of the healthcare system in the United States, striving to improve health outcomes and provide affordable insurance options. The company continues to influence the healthcare industry by enhancing its digital solutions and fostering partnerships that promote integrated care between medical professionals and insurers.
Official SEC Documents
Advertisement